v3.25.2
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Jan. 31, 2025
Jan. 31, 2024
Cash flows from operating activities:        
Net income (loss) $ (336,132) $ 311,381 $ 2,122,189 $ (4,080,258)
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Depreciation 1,618 1,617 6,469 6,152
Stock based compensation 33,348 77,626 679,268 167,953
Amortization of debt discounts 25,049 9,176 145,038 197,477
Gain on change in fair value of derivative liabilities (46,495) (851,032) (4,109,195) 2,386,907
Loss on settlement of liabilities 143,373 46,346 (56,000)
Changes in assets and liabilities:        
Prepaid expenses and other current assets     20,808 17,034
Prepaid expenses (1,878) 347
Accounts payable and accrued expenses 18,171 13,029 68,220 (32,574)
Accrued expenses to related party 3,746 2,143 938
Cash flows used in operating activities: (159,200) (435,713) (1,019,919) (1,393,309)
Cash flows from financing activities:        
Proceeds from advances, related party 75,000 (10,000) 354,693 1,363
Repayments of advances, related party     (25,000) (8,157)
Proceeds from advances     9,000
Repayments of advances (1,000) (17,091)
Proceeds from notes payable, related party 285,000 467,000 285,000
Repayments of notes payable, related party (10,000) (55,000)
Repayments of notes payable     (24,750) (27,604)
Proceeds from convertible promissory notes 125,000 100,000 336,000 175,000
Repayments of convertible promissory notes (123,860) (184,080)
Proceeds from the issuance of common stock for cash, net 91,840 90,919
Proceeds from the issuance of common stock and warrants in a private placement 49,142 1,007,913
Receipt of subscription receivable     16,368
Net cash provided by financing activities 206,122 375,000 968,782 1,432,792
Increase (decrease) in cash and cash equivalents 46,922 (60,713) (51,137) 39,483
Cash and cash equivalents, beginning of period 20,962 72,099 72,099 32,616
Cash and cash equivalents, end of period 67,884 11,386 20,962 72,099
Supplemental disclosure of cash flow information:        
Income tax paid
Interest paid 960 474 948 2,564
Supplemental disclosure of non-cash items:        
Resolution of derivative liabilities due to debt conversions and untainted warrants     52,476 156,309
Reclass of APIC to derivative liabilities for tainted warrants     1,858,199 1,901
Debt discounts due to derivative liabilities     67,352 146,368
Shares issued for conversion of debt and interest 24,640 114,400 233,280
Expenses paid by related party on behalf of the Company     21,827
Prepaid insurance financed with note payable 24,750 24,750 24,750 24,850
Cashless exercise of warrants     16,750
Settlement of subscription and interest receivable 17,230 17,230
Issuance of common stock and warrants for equipment     1,908
Issuance of common stock and warrants for settlement of liabilities     11,114
Shares issued for deferred financing costs     20,000
Issuance of common stock and warrants in private placement 469,775   124,693
Reclassification of deferred financing costs to equity     $ 20,000
Issuance of common stock and warrants in private placement for settlement of liabilities $ 277,260